2 results
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOCompleted
Primary Objective:To assess Laser Detection Rates of A* and C nerve fibers in healthy study subjects.Secondary Objectives:To assess Reaction Time after selective stimulation of A* and C nerve fibers in healthy subjects